BACKGROUND: Efforts to predict psychosis in individuals at high risk for schizophrenia have focused on the identification of sub-threshold clinical criteria and neurobiological markers, including neuropsychological assessment, structural and functional brain imaging, and psychophysiological testing. We sought to evaluate the relative utility of "psychosis-proneness" measures for prospective prediction of psychotic disorders in a group of young relatives at familial risk for schizophrenia. METHODS: We examined the receiver operating characteristics of sub-threshold symptoms in predicting conversion to psychosis in a group of 97 young first- and second- degree relatives of persons with schizophrenia over a 2-year period. Towards this end, we utilized the Structured Interview of prodromal symptoms to derive measures of two of the four Scale of Prodromal Symptoms subscales (positive and disorganized) and the Chapman Magical Ideation and Perceptual Aberration scales. These four measures were, together, taken to reflect a putative index of psychosis-proneness. RESULTS: Eleven of the 97 subjects developed a psychotic disorder over 2 years of follow-up. Seventeen of the 97 subjects tested positive on this index of psychosis-proneness at baseline and of these 10 converted to psychosis. The sensitivity and specificity of the test were 91 percent and 92 percent respectively. The positive predictive value of the test was 59 percent and its negative predictive value was 99 percent. Addition of measures of cognitive or social function to the index decreased its predictive ability, reducing its specificity and/or sensitivity. CONCLUSIONS: A relatively simple set of clinical measures can be utilized to prospectively identify familial high risk individuals who convert to psychosis with high specificity and sensitivity. Implications for the proposed addition of an "attenuated psychosis syndrome" in DSM-5 are discussed.
BACKGROUND: Efforts to predict psychosis in individuals at high risk for schizophrenia have focused on the identification of sub-threshold clinical criteria and neurobiological markers, including neuropsychological assessment, structural and functional brain imaging, and psychophysiological testing. We sought to evaluate the relative utility of "psychosis-proneness" measures for prospective prediction of psychotic disorders in a group of young relatives at familial risk for schizophrenia. METHODS: We examined the receiver operating characteristics of sub-threshold symptoms in predicting conversion to psychosis in a group of 97 young first- and second- degree relatives of persons with schizophrenia over a 2-year period. Towards this end, we utilized the Structured Interview of prodromal symptoms to derive measures of two of the four Scale of Prodromal Symptoms subscales (positive and disorganized) and the Chapman Magical Ideation and Perceptual Aberration scales. These four measures were, together, taken to reflect a putative index of psychosis-proneness. RESULTS: Eleven of the 97 subjects developed a psychotic disorder over 2 years of follow-up. Seventeen of the 97 subjects tested positive on this index of psychosis-proneness at baseline and of these 10 converted to psychosis. The sensitivity and specificity of the test were 91 percent and 92 percent respectively. The positive predictive value of the test was 59 percent and its negative predictive value was 99 percent. Addition of measures of cognitive or social function to the index decreased its predictive ability, reducing its specificity and/or sensitivity. CONCLUSIONS: A relatively simple set of clinical measures can be utilized to prospectively identify familial high risk individuals who convert to psychosis with high specificity and sensitivity. Implications for the proposed addition of an "attenuated psychosis syndrome" in DSM-5 are discussed.
Authors: Danielle A Schlosser; Jamie L Zinberg; Rachel L Loewy; Shannon Casey-Cannon; Mary P O'Brien; Carrie E Bearden; Sophia Vinogradov; Tyrone D Cannon Journal: Schizophr Res Date: 2010-02-19 Impact factor: 4.939
Authors: R Smieskova; P Fusar-Poli; P Allen; K Bendfeldt; R D Stieglitz; J Drewe; E W Radue; P K McGuire; A Riecher-Rössler; S J Borgwardt Journal: Neurosci Biobehav Rev Date: 2010-02-06 Impact factor: 8.989
Authors: Christoph U Correll; Marta Hauser; Andrea M Auther; Barbara A Cornblatt Journal: J Child Psychol Psychiatry Date: 2010-02-26 Impact factor: 8.982
Authors: Tejas S Bhojraj; Vaibhav A Diwadkar; John A Sweeney; Konasale M Prasad; Shaun M Eack; Debra M Montrose; Matcheri S Keshavan Journal: Prog Neuropsychopharmacol Biol Psychiatry Date: 2010-01-29 Impact factor: 5.067
Authors: Stephan Ruhrmann; Frauke Schultze-Lutter; Raimo K R Salokangas; Markus Heinimaa; Don Linszen; Peter Dingemans; Max Birchwood; Paul Patterson; Georg Juckel; Andreas Heinz; Anthony Morrison; Shôn Lewis; Heinrich Graf von Reventlow; Joachim Klosterkötter Journal: Arch Gen Psychiatry Date: 2010-03
Authors: Scott W Woods; Jean Addington; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Robert Heinssen; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Thomas H McGlashan Journal: Schizophr Bull Date: 2009-04-21 Impact factor: 9.306
Authors: Patrick D McGorry; Barnaby Nelson; G Paul Amminger; Andreas Bechdolf; Shona M Francey; Gregor Berger; Anita Riecher-Rössler; Joachim Klosterkötter; Stephan Ruhrmann; Frauke Schultze-Lutter; Merete Nordentoft; Ian Hickie; Philip McGuire; Michael Berk; Eric Y H Chen; Matcheri S Keshavan; Alison R Yung Journal: J Clin Psychiatry Date: 2009-06-30 Impact factor: 4.384
Authors: Nikolaos Koutsouleris; Eva M Meisenzahl; Christos Davatzikos; Ronald Bottlender; Thomas Frodl; Johanna Scheuerecker; Gisela Schmitt; Thomas Zetzsche; Petra Decker; Maximilian Reiser; Hans-Jürgen Möller; Christian Gaser Journal: Arch Gen Psychiatry Date: 2009-07
Authors: Eduardo Fonseca-Pedrero; Javier Ortuño; Martin Debbané; Raymond C K Chan; David Cicero; Lisa C Zhang; Colleen Brenner; Emma Barkus; Richard J Linscott; Thomas Kwapil; Neus Barrantes-Vidal; Alex Cohen; Adrian Raine; Michael T Compton; Erin B Tone; Julie Suhr; Felix Inchausti; Julio Bobes; Axit Fumero; Stella Giakoumaki; Ioannis Tsaousis; Antonio Preti; Michael Chmielewski; Julien Laloyaux; Anwar Mechri; Mohamed Aymen Lahmar; Viviana Wuthrich; Frank Larøi; Johanna C Badcock; Assen Jablensky; Adela M Isvoranu; Sacha Epskamp; Eiko I Fried Journal: Schizophr Bull Date: 2018-10-15 Impact factor: 9.306
Authors: Jai Shah; Shaun M Eack; Debra M Montrose; Neeraj Tandon; Jean M Miewald; Konasale M Prasad; Matcheri S Keshavan Journal: Schizophr Res Date: 2012-09-23 Impact factor: 4.939
Authors: Jai L Shah; Neeraj Tandon; Debra M Montrose; Diana Mermon; Shaun M Eack; Jean Miewald; Matcheri S Keshavan Journal: Early Interv Psychiatry Date: 2017-09-07 Impact factor: 2.732
Authors: E De la Serna; D Ilzarbe; G Sugranyes; I Baeza; D Moreno; E Rodríguez-Toscano; A Espliego; M Ayora; S Romero; V Sánchez-Gistau; J Castro-Fornieles Journal: Eur Child Adolesc Psychiatry Date: 2020-03-07 Impact factor: 4.785
Authors: Halide Bilge Türközer; Elena I Ivleva; Jayme Palka; Brett A Clementz; Rebecca Shafee; Godfrey D Pearlson; John A Sweeney; Matcheri S Keshavan; Elliot S Gershon; Carol A Tamminga Journal: Schizophr Bull Date: 2021-07-08 Impact factor: 9.306